한국어
English
日本語
中文(简体)
Lumacras 120 mg Tablets (Sotorasib)
120mg
Tablet · Prescription medication
Amgen Korea Ltd.
Sotorasib is an anti-cancer drug component that inhibits the growth of certain cancer cells.
MFDS ingredient code M282025
Sotorasib is a molecular targeted therapy used as an antineoplastic agent. It primarily targets cancer cells with specific genetic mutations to demonstrate therapeutic effects. This component is used to block the abnormal signaling of cancer cells.
Sotorasib binds to specific mutated proteins within cancer cells to block that signaling pathway. By doing so, it interferes with the processes that allow cancer cells to proliferate and survive, thereby delaying or stopping the progression of cancer.
Approved uses differ by product. Check each product's information for its actual use.
Sotorasib is a targeted therapy specialized for specific genetic mutations, which, unlike conventional chemotherapy, causes less damage to normal cells and selectively attacks only cancer cells. This contributes to reducing side effects and enhancing therapeutic efficacy.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.